XML 109 R81.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details) - USD ($)
 1 Months Ended 2 Months Ended 9 Months Ended
Nov. 17, 2022
Nov. 11, 2022
Oct. 17, 2022
May 12, 2022
Feb. 15, 2022
Jan. 10, 2022
Jan. 27, 2022
Nov. 30, 2022
Sep. 30, 2022
Nov. 10, 2022
Oct. 10, 2022
Apr. 18, 2022
Apr. 11, 2022
Mar. 30, 2022
Feb. 28, 2022
Feb. 14, 2022
Dec. 31, 2021
Dec. 20, 2021
Jan. 11, 2021
Dec. 31, 2020
Subsequent Events (Details) [Line Items]                                        
Debt instrument, repurchase amount                                 $ 51,000,000      
Preference shares, authorized                 20,000,000               20,000,000     20,000,000
Preferred Stock, Par or Stated Value Per Share                 $ 0.0001               $ 0.0001     $ 0.0001
Minimum net worth to consummate business combination     $ 5,000,001                                  
Funding Commitment Letter [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Line of Credit Facility, Maximum Borrowing Capacity     10,000,000                                  
Aggregate Outstanding Amount     310,000,000                                  
Sorrento [Member] | Two Thousand And Twenty Two Promissory Note [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument, term       7 years                                
Debt instrument, interest rate, stated percentage       2.66%                                
Sorrento [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument, repurchase amount                 $ 100,000,000                 $ 51,000,000   $ 13,700,000
Scilex Pharma Note [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument, interest rate, stated percentage                                 7.70%     9.15%
Scilex Pharma Note [Member] | Subordinated Debt [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument face amount                               $ 35,000,000        
Debt instrument, repurchase amount                             $ 20,000,000          
Restricted cash                             10,000,000          
Vicker's Vantage                                        
Subsequent Events (Details) [Line Items]                                        
Contribution per share                                   $ 0.75 $ 10  
Sponsor loan           $ 1,035,000                            
Debt instrument face amount                       $ 500,000 $ 1,500,000         $ 500,000    
Preference shares, authorized                 1,000,000               1,000,000     1,000,000
Preferred Stock, Par or Stated Value Per Share                 $ 0.0001               $ 0.0001     $ 0.0001
Vicker's Vantage | Maximum [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Preference shares, authorized                 45,000,000                      
Vicker's Vantage | Minimum [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Preference shares, authorized                 20,000,000                      
Subsequent Event [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Minimum time declared to file with sec regarding resale registration statement       60 days                                
Minimum net worth to consummate business combination     5,000,001                                  
Subsequent Event [Member] | Yorkville [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Issuance of aggregate ordinary shares (in Shares)                 250,000                      
Subsequent Event [Member] | Standby Equity Purchase Agreement [Member] | Yorkville [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Common stock shares subscribed but not issued value   $ 500,000,000                                    
Period After Registration When The Request Could Be Made To The Investee To Purchase The Shares   36 months                                    
Maximum Percentage Of Volume Weighted Average Price Of Shares Measured On A Daily Basis That Is Eligible To Be Received As Advance 200.00%                                      
Number Of Threshold Trading Days Prior To Date Of Notice To The Shareholders For Determining The Volume Weighted Average Price Of Shares 5 days                                      
Percentage Of Daily Volume Weighted Average Price Of Shares At Which The Shares Are Eligible To Be Purchased 98.00%                                      
Number Of Consecutive Trading Days For Determining The Volume Weighted Average Price Of Shares 2 days                                      
Subsequent Event [Member] | Funding Commitment Letter [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Line of Credit Facility, Maximum Borrowing Capacity     10,000,000                                  
Aggregate Outstanding Amount     $ 310,000,000                                  
Subsequent Event [Member] | Series A Preferred Stock [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Preferred Stock, Par or Stated Value Per Share                   $ 0.0001                    
Subsequent Event [Member] | Maximum [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Preference shares, authorized                   45,000,000                    
Subsequent Event [Member] | Minimum [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Preference shares, authorized                   20,000,000                    
Subsequent Event [Member] | Aardvark [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Asset acquisition, consideration transferred       $ 3,000,000                                
Payments to acquire productive assets       20,000,000                                
Subsequent Event [Member] | Sorrento [Member] | Two Thousand And Twenty Two Promissory Note [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument face amount       $ 5,000,000                                
Debt instrument, term       7 years                                
Debt instrument, interest rate, stated percentage       2.66%                                
Minimum time declared to file with sec regarding resale registration statement       60 days                                
Subsequent Event [Member] | Sorrento [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Notes payable, related parties                           $ 23,000,000            
Subsequent Event [Member] | Scilex Pharma Note [Member] | Subordinated Debt [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument face amount                               $ 35,000,000        
Debt instrument, repurchase amount                             $ 20,000,000          
Percentage of purchase price in cash equal is to principal amount of the loan                             100.00%          
Restricted cash                             $ 10,000,000          
Sales threshold limit         $ 481,000,000                              
Subsequent Event [Member] | Scilex Pharma Note [Member] | Subordinated Debt [Member] | Maximum [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Debt instrument face amount         $ 28,000,000                              
Subsequent Event [Member] | Vicker's Vantage                                        
Subsequent Events (Details) [Line Items]                                        
Sponsors deposited (in Dollars)                     $ 323,889                  
Common stock par value     $ 0.0001                                  
Contribution per share     $ 10     $ 0.75                            
Number of shares (in Shares)     1,500,000                                  
Warrant Exercise Price           $ 0.75                            
Additional principal amount             $ 500,000                          
Convertible Promissory Note             $ 2,035,000                          
Subsequent Event [Member] | Sorrento [Member] | Agreement With Certain Of The Third Party Professional Service Providers [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Liabilities assumed in a non cash transaction               $ 11,900,000                        
Subsequent Event [Member] | Sorrento [Member] | Agreement With Certain Of The Third Party Professional Service Providers [Member] | Accounts Payable [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Liabilities assumed in a non cash transaction               10,000,000                        
Subsequent Event [Member] | Sorrento [Member] | Agreement With Certain Of The Third Party Professional Service Providers [Member] | Accrued Liabilities [Member]                                        
Subsequent Events (Details) [Line Items]                                        
Liabilities assumed in a non cash transaction               $ 1,900,000